Search

Your search keyword '"Acinetobacter baumannii genetics"' showing total 2,812 results

Search Constraints

Start Over You searched for: Descriptor "Acinetobacter baumannii genetics" Remove constraint Descriptor: "Acinetobacter baumannii genetics"
2,812 results on '"Acinetobacter baumannii genetics"'

Search Results

1. Electrochemical biosensing of Acinetobacter baumannii gene using chitosan-gold composite modified electrode.

2. Cryo-EM characterization of the anydromuropeptide permease AmpG central to bacterial fitness and β-lactam antibiotic resistance.

3. A novel machine-learning aided platform for rapid detection of urine ESBLs and carbapenemases: URECA-LAMP.

4. Inserting Omp22 into the flagellin protein, replacing its hypervariable region, results in stronger protection against lethal Acinetobacter baumannii infection.

5. Antimicrobial susceptibility to last-resort antibiotics in carbapenemase-producing bacteria from Ukrainian patients.

6. Modular, inducible, and titratable expression systems for Escherichia coli and Acinetobacter baumannii .

7. Genome analysis of tigecycline-resistant Acinetobacter baumannii reveals nosocomial lineage shifts and novel resistance mechanisms.

8. Longitudinal genomics reveals carbapenem-resistant Acinetobacter baumannii population changes with emergence of highly resistant ST164 clone.

9. Uncovering the transcriptome-wide RNA modifications in Acinetobacter baumannii .

10. H-NS is a Transcriptional Repressor of the CRISPR-Cas System in Acinetobacter baumannii ATCC 19606.

11. Investigating an outbreak of extensively drug-resistant Acinetobacter baumannii in a tertiary healthcare centre in lebanon using next-generation sequencing.

12. In-vitro activities of essential antimicrobial agents including aztreonam/avibactam, eravacycline, colistin and other comparators against carbapenem-resistant bacteria with different carbapenemase genes: A multi-centre study in China, 2021.

13. Clinical, phenotypic characterization and genomic analysis of the mucoid Acinetobacter baumannii from a teaching hospital.

14. In vitro resistance development gives insights into molecular resistance mechanisms against cefiderocol.

15. A single-center analysis of clonal transmission of carbapenem-resistant Acinetobacter baumannii among intensive care unit patients during the COVID-19 pandemic.

16. Insights into Acinetobacter baumannii AMA205's Unprecedented Antibiotic Resistance.

17. Differential effects of inosine monophosphate dehydrogenase (IMPDH/GuaB) inhibition in Acinetobacter baumannii and Escherichia coli .

18. Characterization of the carbapenem-resistant Acinetobacter baumannii clinical reference isolate BAL062 (CC2:KL58:OCL1): resistance properties and capsular polysaccharide structure.

19. Outbreak with OXA-23-producing Acinetobacter baumannii in a COVID-19 ICU cohort: unraveling routes of transmission.

20. Heterogeneity and Genomic Plasticity of Acinetobacter baumannii and Acinetobacter nosocomialis Isolates Recovered from Clinical Samples in India.

21. Genomic surveillance as a scalable framework for precision phage therapy against antibiotic-resistant pathogens.

22. Host population structure and species resolution reveal prophage transmission dynamics.

23. Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam.

24. Intragenomic conflicts with plasmids and chromosomal mobile genetic elements drive the evolution of natural transformation within species.

25. Global analysis of the RNA-RNA interactome in Acinetobacter baumannii AB5075 uncovers a small regulatory RNA repressing the virulence-related outer membrane protein CarO.

26. AbAMPdb: a database of Acinetobacter baumannii specific antimicrobial peptides.

27. Crystal Structures of the Acinetobacter baumannii Macrolide Phosphotransferase E.

28. Analysis of risk factors and different treatments for infections caused by carbapenem-resistant Acinetobacter baumannii in Shaanxi, China.

29. The context of bla OXA-23 gene in Iraqi carbapenem-resistant Acinetobacter baumannii isolates belonging to global clone 1 and global clone 2.

30. Structure of a Rhs effector clade domain provides mechanistic insights into type VI secretion system toxin delivery.

31. Impact of acidic and alkaline conditions on Staphylococcus aureus and Acinetobacter baumannii interactions and their biofilms.

32. Acinetobacter baumannii transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti- Acinetobacter drug development and AMR preparedness.

33. The novel MFS efflux pump SxtP, regulated by the LysR-type transcriptional activator SxtR, is involved in the susceptibility to sulfamethoxazole/trimethoprim (SXT) and the pathogenesis of Acinetobacter baumannii .

34. Experimental evolution under different nutritional conditions changes the genomic architecture and virulence of Acinetobacter baumannii.

35. Role of the NtrC family response regulator in nitrogen metabolism of Acinetobacter baumannii.

36. A unique cell division protein critical for the assembly of the bacterial divisome.

37. Lipidomic analyses reveal distinctive variations in homeoviscous adaptation among clinical strains of Acinetobacter baumannii , providing insights from an environmental adaptation perspective.

38. Acinetobacter calcoaceticus-baumannii complex prevalence, spatial-temporal distribution, and contamination sources in Canadian aquatic environments.

39. Hetero-antagonism of avibactam and sulbactam with cefiderocol in carbapenem-resistant Acinetobacter spp.

40. Genomic epidemiology and resistant genes of Acinetobacter baumannii clinical strains in Vietnamese hospitals.

41. Genomics unveils country-to-country transmission between animal hospitals of a multidrug-resistant and sequence type 2 Acinetobacter baumannii clone.

42. Biofilm formation, antibiotic-resistance and clonal relatedness among clinical isolates of Acinetobacterbaumannii.

43. Pan-pathogen deep sequencing of nosocomial bacterial pathogens in Italy in spring 2020: a prospective cohort study.

44. Colorimetric Loop-Mediated Isothermal Amplification Assays Accurately Detect bla OXA-23-like and ISAba1 Genes from Acinetobacter baumannii in Pure Cultures and Spiked Human Sera.

45. Antibacterial activity evaluation of a novel K3-specific phage against Acinetobacter baumannii and evidence for receptor-binding domain transfer across morphologies.

46. An outbreak of severe or lethal infections by a multidrug-resistant Acinetobacter baumannii ST126 strain carrying a plasmid with bla NDM-1 and bla OXA-58 carbapenemases.

47. Acinetobacter baumannii clinical isolates from outbreaks in Erbil hospitals after the COVID-19 pandemic.

48. Analysis of antimicrobial resistance and genetic diversity of Acinetobacter baumannii in a tertiary care hospital in Haikou City.

49. Manipulation of natural transformation by AbaR-type islands promotes fixation of antibiotic resistance in Acinetobacter baumannii .

50. Environmental contamination with carbapenem resistant Acinetobacter baumannii in healthcare settings in Fiji: a potential source of infection.

Catalog

Books, media, physical & digital resources